Knezevic, Ivana <br/><br/>
1st WHO International Standard antiserum to RSV: Availability and benefits for RSV vaccine development (Commentary on the collaborative study report published in the vaccine journal (Vaccine 2018 36: 7641-7649)).  [electronic resource] 

 -  Vaccine  07 2019 
 - 4233-4235 p.  digital 
<br/><br/> Publication Type: Journal Article; Comment 
<br/><br/><label>ISSN: </label>1873-2518 
<br/><br/><label>Standard No.: </label>10.1016/j.vaccine.2019.06.022  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Immune Sera<br/>Respiratory Syncytial Virus Vaccines<br/>Respiratory Syncytial Virus, Human